Clinical Trialist Development Award (CTDA)

Closes On

24 May 2024

Funding Source

Internal

PI Salary Support

ACP/SDDC Affiliation

No ACP/SDDC affiliation required

Funding Per Grant Non-Monetary Support

Protected time for 2 years (0.2 FTE for Clinical Trialist; 0.4 FTE for Master Clinical Trialist)

Qualification

Not Specified

Academic Appointment

Funding Period

2 years

Citizenship

Foreigner / S / PR

Call Opens

15 Apr 2024

SMC/SDC Registered

Objective

Academic talent development initiatives to recognise and support Clinician Investigators and Clinical Trialists in SingHealth Duke-NUS Academic Medical Centre (AMC).

Clinical Trialist Development Award (CTDA) is to recognise and promote interest in pursuing clinical research that will enhance institutional and national prestige and reputation, and to provide protected time for Clinical Trialists to focus on clinical trials and ensure successful recruitment, good quality of care and patient safety.

Funding Details

A prestigious award that provides protected time for 2 years (0.2 FTE for Clinical Trialist; 0.4 FTE for Master Clinical Trialist), with the aim to develop clinicians with expertise and interest in the conduct of clinical trials.

Eligibility Criteria

Applicants can apply for either the "Clinical Trialist" or the "Master Clinical Trialist" provided they fulfil the following eligibility criteria as stated in the table below.

Clinical Trialist

Master Clinical Trialist

A Clinician who:

Is a PI of 2 or more Clinical Trials in the past 2 years;
Secured trial contract value of >S$500,000 over a 2-year period and
Achieved average recruitment target of ≥50% for all the trials in the past 2 years

OR
Is overall Chief PI of Investigator Initiated Clinical Trial who has designed the trial and secured funding for the trial with contract value of >S$500,000

A Clinician who:

Is a PI of 5 or more Clinical Trials in the past 2 years;
Secured trial contract value of >S$1 million over a 2-year period and
Achieved recruitment target of ≥50% for all the trials in the past 2 years

OR
Is overall Chief PI of Investigator Initiated Clinical Trial who has designed the trial and secured funding for the trial with contract value of >S$1 million

Submission

Interested applicants are to submit the following completed files using the templates found in the zipped file for the programme through your respective ACP to Joint Office of Academic Medicine at academic-medicine@duke-nus.edu.sg by 24 May 2024 (Friday), 5pm.

Application Form (to be completed by applicant)
Applicant CV & Career Development Plan (to be completed by applicant)
Nomination Form (to be completed and endorsed by Clinical HOD, ACP Chair and SDDC Head (where applicable))

Note: SingHealth PIs are to please refer to your respective ACP Administrators for guidance on internal deadlines and submission procedures set by your ACP.

Contact Person

For enquiries, please contact academic-medicine@duke-nus.edu.sg.

Additional Information

Please visit CTDP's website here.

For more information, please refer to zipped file below:

CTDA.zip